An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Trial details
- Registry ID
- NCT07365332
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)NCT07365332 | Inhibikase Therapeutics | Phase 3 | Recruiting | 2029-06Estimated |
| Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH)NCT07632898 | Inhibikase Therapeutics | Phase 3 | Not yet recruiting | 2030-06-30Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |